Cisatracurium Besylate
Cisatracurium Besylate is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
3 of 3 finished
0.0%
0 ended early
0
trials recruiting
5
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Effect of Addition of Cisatracurium to Lidocaine VS Plain Lidocaine
Effect of Remimazolam vs Sevoflurane Anesthesia on Incidence of Emergence Agitation and Complications in Children Undergoing Ophthalmic Surgery
Effect of Rematazolam Besylate, Propofol, and Sevoflurane Perioperative Sedation on Incidence of Emergence Agitation and Hemodynamics in Patients Undergoing Laparoscopic Abdominal Surgery
Efficacy and Safety Profile of Cisatracurium Besylate for IAH
Reevaluation Of Systemic Early Neuromuscular Blockade
Clinical Trials (5)
Effect of Addition of Cisatracurium to Lidocaine VS Plain Lidocaine
Effect of Remimazolam vs Sevoflurane Anesthesia on Incidence of Emergence Agitation and Complications in Children Undergoing Ophthalmic Surgery
Effect of Rematazolam Besylate, Propofol, and Sevoflurane Perioperative Sedation on Incidence of Emergence Agitation and Hemodynamics in Patients Undergoing Laparoscopic Abdominal Surgery
Efficacy and Safety Profile of Cisatracurium Besylate for IAH
Reevaluation Of Systemic Early Neuromuscular Blockade
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5